Gene-Disorder Association · Article
Gene
SCN1A Sodium Voltage-Gated Channel Alpha Subunit 1
×
First reported
2001
Supporting publications
49
Manually curated Approved treatment annotated
Association Review
In brief The association between SCN1A (Sodium Voltage-Gated Channel Alpha Subunit 1) and Epilepsy is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording likely-pathogenic variants.
Sources
2
Clinical variants
68
Symptoms
11
Compounds
17
Trials
270 of 1,277 via SCN1A compounds
Publications
49
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 2 sources
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
11 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
ClinVar and variant evidence
Genetic basis 68 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
06
Population genetics
GWAS signals 4 GWAS phenotypes
Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.
Request access
07
Mechanism overlap
Shared mechanisms 1 shared pathway
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
08
Interventions
Therapeutics 17 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
09
Human studies
Clinical trials 1,277 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
49 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
11
Provenance
References & sources 20 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access